---
module: 071-03
language: en
chapter: 71
title: "Primary Care, Prevention, Multimorbidity, and Continuity"
module_title: "Management, monitoring, prevention, safety, ethics, systems issues, and longitudinal care"
source_sha256: deec283c5ec893295baea398944b7bd404e0e6c5b3e0d78cbf882ba8274678b0
---
# Longitudinal management in primary care

## Goals before disease targets
### Reduce harm without overwhelming the person
#### Each addition needs purpose, review, stopping rule
### Start from what matters most to the person
#### Translate values into measurable goals
### Shared decisions still include clear advice
### Relax targets when harm outweighs benefit
#### Age alone does not exclude effective therapy
### One integrated plan with named owners
#### Patient is not the only information conduit

## Polypharmacy as dynamic exposure
### Verify what is actually taken
#### Ask how medicines are organised and missed
### Prescribing cascade
#### Adverse effect treated as a new condition
#### Time new symptoms against medication changes
### Deprescribing when harm exceeds benefit
#### No indication, duplication, high-risk combinations
#### Taper some, change few, monitor outcome
### Transitions are high risk
#### Reconcile what stopped, started, changed
#### Dosing aids do not solve intentional non-use

## Monitoring that answers questions
### Control, toxicity, adherence, progression
### Interval from kinetics, stability, actionability
#### Too often detects noise, too rarely misses decline
### Condition reviews beyond refills
### Home monitoring: agency versus anxiety
#### Validated devices and response pathway
#### Wearables give false alarms

## Prevention by absolute benefit
### Life-course review of preventive care
#### Bundle, but do not displace the concern
### Smoking cessation benefits at every age
### Weight counselling without stigma
### Specific physical activity prescriptions
### Screening weighs life expectancy, overdiagnosis
#### Stopping must not imply life matters less

## Adherence by reducing friction
### Intentional, unintentional, structural
#### Diagnose the barrier, not moral failure
### Simplify dosing, align refills, involve pharmacists
### Teach-back and motivational interviewing
### Written action plans for episodic conditions
#### Baseline, warning signs, steps, when to seek help

## Referrals and transitions
### Referral states question, urgency, goals
### Referrer responsible until transfer accepted
#### Bridging care and escalation criteria
### Reconcile advice with whole-person plan
### Early post-discharge period is high risk
#### Early contact checks symptoms, medicines, support
### Multidisciplinary care needs explicit roles

## Digital care and access
### Telehealth cannot replace every examination
#### Confirm identity, location, privacy
### Portals may exclude some patients
#### Urgent symptoms not via asynchronous messages
### Automated summaries need verification
### Missed appointments are clinical information
#### Proportionate outreach

## Relational ethics
### Warmth within professional limits
### Confidentiality in family and community
### Honest disclosure of errors and delays
#### Second opinion or complaint without fear
### Carer involvement with consent
#### Assess carer health separately
### Changed capacity: legal pathway, prior values

## Success through function and experience
### Outcomes beyond biomarkers
#### Lower value is not success if patient falls
### Periodic whole-plan reviews
#### Ask what could be stopped
### Anticipatory and advance care planning
### Cycle: prioritise, act, measure, simplify, revise
